Schroder Investment Management Group Sells 24,789 Shares of Novanta Inc. $NOVT

Schroder Investment Management Group cut its holdings in Novanta Inc. (NASDAQ:NOVT) by 11.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 196,049 shares of the technology company’s stock after selling 24,789 shares during the quarter. Schroder Investment Management Group owned approximately 0.55% of Novanta worth $19,615,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of NOVT. Pilgrim Partners Asia Pte Ltd acquired a new position in Novanta during the third quarter worth about $36,000. Migdal Insurance & Financial Holdings Ltd. acquired a new stake in shares of Novanta in the 3rd quarter valued at approximately $40,000. Harbor Investment Advisory LLC grew its holdings in shares of Novanta by 47.1% during the 3rd quarter. Harbor Investment Advisory LLC now owns 987 shares of the technology company’s stock valued at $99,000 after purchasing an additional 316 shares during the last quarter. Inceptionr LLC bought a new stake in shares of Novanta during the 2nd quarter valued at approximately $213,000. Finally, Blueshift Asset Management LLC acquired a new position in Novanta during the 2nd quarter worth approximately $213,000. Institutional investors own 98.35% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the sale, the chief executive officer directly owned 57,367 shares in the company, valued at $8,320,509.68. This represents a 11.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Robert Buckley sold 1,423 shares of the firm’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $140.88, for a total value of $200,472.24. Following the transaction, the chief financial officer directly owned 93,814 shares of the company’s stock, valued at approximately $13,216,516.32. This represents a 1.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 24,346 shares of company stock worth $3,382,737. 1.20% of the stock is owned by company insiders.

Novanta Stock Performance

Novanta stock opened at $119.54 on Friday. The business has a 50 day moving average of $135.17 and a 200-day moving average of $121.16. The company has a market capitalization of $4.27 billion, a P/E ratio of 81.88 and a beta of 1.61. Novanta Inc. has a 1 year low of $98.27 and a 1 year high of $149.95. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.69 and a quick ratio of 2.80.

Novanta (NASDAQ:NOVT) last posted its earnings results on Monday, February 23rd. The technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.88 by $0.03. Novanta had a net margin of 5.49% and a return on equity of 13.12%. The business had revenue of $258.35 million for the quarter, compared to the consensus estimate of $260.72 million. During the same period last year, the company earned $0.76 EPS. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. On average, equities research analysts predict that Novanta Inc. will post 3.03 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages recently commented on NOVT. Zacks Research raised shares of Novanta from a “strong sell” rating to a “hold” rating in a research note on Friday, January 16th. Robert W. Baird set a $150.00 price target on shares of Novanta in a report on Wednesday, February 25th. Finally, Weiss Ratings upgraded Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Tuesday, January 20th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Novanta presently has an average rating of “Hold” and an average target price of $150.00.

Novanta Company Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.